Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Haynes: Role of IgA in HIV-1 Protection |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2012-11-19 |
| Study Made Public: | 2013-05-21 |
Title
C1 peptide immunogenicity study
Description
CAVD 394 is a non-human primate study to evaluate the neutralization activity of a regimen using a C1 peptide and the adjuvants, MF59, TLR7, and TLR9.
Sign in to see full information about this study and to download study data.
Products
MF59 TLR7 C1 peptide TLR9Integrated data
NAb
Non-integrated data
No non-integrated data is available for this study.